Navigation Links
Europe is joining forces against neglected parasitic diseases
Date:3/4/2014

The project involves 10 European partners, 5 Brazilian partners (who operate in the region where the diseases are endemic) and 2 Australian partners. They will all be meeting on 17 and 18 March at the Institute of Genetics and Molecular and Cellular Biology (Inserm / CNRS / University of Strasbourg Joint Research Unit), to get the project started.

Schistosomiasis, leishmaniasis, Chagas disease and malaria are regarded as neglected diseases because the effort and funds put into developing new treatment and control methods have not been commensurate with their catastrophic human impact. They affect people in developing countries, essentially in Africa, the Middle East, South America and eastern Asia, in tropical and sub-tropical regions. Around one billion people are regularly exposed to these diseases, which cause almost one million deaths every year.

At present, there is no vaccine against these parasites. Furthermore, the efficacy of existing treatments is limited, either by the side effects or by the current or potential development of resistance. Consequently, the A-PARADDISE consortium, which is coordinated by Inserm and headed by Raymond Pierce - Director of Research at the Centre for Infection and Immunity in Lille - is focusing on developing new drugs against these parasitoses.

The A-PARADDISE project will use a methodology that has already been tried and tested during a previous project of a similar scale (SEtTReND), which aimed to develop drugs against schistosomiasis. The researchers investigated histone-modifying enzymes (HME), which determine the structure of the parasite's chromosomes. It was demonstrated that some HME inhibitors induce cell death, which makes them toxic to this parasite. This research provided the proof of concept that HMEs act on the schistosomiasis parasite, and has led to the development of a bank of candidate compounds which can rapidly be tested against other human parasites.

Thanks t
'/>"/>

Contact: Raymond Pierce
Raymond.Pierce@pasteur-lille.fr
33-320-877-783
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1 2

Related biology news :

1. European flood risk could double by 2050
2. Researchers shed new light on the genetic history of the European beaver
3. European Union launches Nordic climate innovation center
4. Unique new dataset CLIMBER: Climatic niche characteristics of the butterflies in Europe
5. Are invasive plants a problem in Europe? Controversial views among invasion biologists
6. Scandinavia joins European Unions main climate innovation initiative
7. Blue eyes and dark skin, thats how the European hunter-gatherer looked
8. European epilepsy consortium identifies new gene for severe childhood epilepsy
9. Meloidogyne mali: A new invasive plant parasitic nematode in Europe
10. Aspartame passes stiff review by European Food Safety Authority
11. Europes rarest orchid rediscovered on lost world volcano in the Azores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... single computer cannot always find the solution a user ... cluster of computers that analyze a massive data set ... history to present you with targeted ads, and how ... movie. But big data is about more than just ... are generating unprecedented quantities of information. That data may ...
(Date:7/25/2014)... The burn scars on this false-color image from the Terra ... this year,s rash of wildfires in Eastern Russia. The ... the green background. The wildfires have broken across the ... Even in this false-color image from the MODIS instrument, ... the fires that continue. Two recent image features noted below ...
(Date:7/25/2014)... Nearly 600 scientists from 25 countries and ... Meeting organized by the Genetics Society of America ... in Seattle. The conference will feature close to ... results on topics including gene expression and regulation, ... technologies, evolution, aging, and a variety of diseases. ...
Breaking Biology News(10 mins):New tools help neuroscientists analyze 'big data' 2New tools help neuroscientists analyze 'big data' 3New tools help neuroscientists analyze 'big data' 4New tools help neuroscientists analyze 'big data' 5Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2
... delay the onset of Alzheimer,s disease, but none are able ... detection the key to Alzheimers patients maintaining a good quality ... a new device developed by the Georgia Institute of Technology ... inexpensive test that could be administered as part of a ...
... experiments was to test a computer algorithms ability to ... and classify them according to different contexts and individual ... 14 Hungarian sheepdogs (Mudi breed) in six different situations: ... were recorded with a tape recorder before being transferred ...
... plant material and burn it. If managed well most of ... by the growing plants, and so have a low impact ... the growing plants could be used to help solve other ... from the Department of Energy and Environment at Chalmers University ...
Cached Biology News:Portable device quickly detects early Alzheimer's 2Portable device quickly detects early Alzheimer's 3Biomass production -- careful planning can bring many benefits 2
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... PARK, Calif. , July 24, 2014 /PRNewswire/ ... company in the emerging field of regenerative medicine, ... webcast of a presentation to investors on Tuesday, ... p.m. PDT.  The presentation will include an overview ... To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... materialise. Yet, scientists are making progress in devising ... such approach relies on quantum dotsa kind of ... field. A new study demonstrates that changing the ... with electrical impulses can help better control them. ... used as quantum information units, which would produce ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... N.Y., Dec. 9, 2011 BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... and Eurasia, today announced the appointment of  George Gould, ... 2011.  Mr. Gould, an attorney, is Principal of George ...
... RESEARCH TRIANGLE PARK, N.C., Dec. 9, 2011  CeNeRx ... commercializing innovative treatments for diseases of the central ... $4.85 million financing.  Existing investors Perseus Soros Biopharmaceutical ... Funds all participated in the financing.  CeNeRx plans ...
... LA CROSSE, Wis., Dec. 8, 2011  Prem Rabindranauth, MD, a ... in La Crosse, Wis., is using an ... to perform heart bypass surgery. To perform MICS, a very ... long cut through the breast bone that is needed with ...
Cached Biology Technology:BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 2BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 3BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors 4CeNeRx BioPharma Completes $4.85 Million Financing 2CeNeRx BioPharma Completes $4.85 Million Financing 3Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery 2
... number is a new product number, ... number. If showing no availability yet, ... number (Z71,487-9) or contact customer service ... neck 100 mm, No. of sidearm ...
... a metabolically stable analog of ... uterine stimulant and abortifacient which ... induce labor. It induces luteolysis ... when given as an intramuscular ...
TGase3 (S-20)...
Amodiaquine...
Biology Products: